Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Protein C Deficiency”

32 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 32 results

Not applicableStudy completedNCT00014859
What this trial is testing

Epidemiology of Surfactant Protein-B Deficiency

Who this might be right for
Lung DiseasesRespiratory Distress Syndrome, NewbornPulmonary Surfactant+1 more
Washington University School of Medicine 5,176
Early research (Phase 1)Study completedNCT02997969
What this trial is testing

Safety and Immune Response to a Clade C DNA HIV Vaccine

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 132
Not applicableUnknownNCT04180657
What this trial is testing

Ghrelin Levels in Patients With Protein C Deficiency

Who this might be right for
Protein C Deficiency
University of Aarhus 60
Not applicableEnrolling By InvitationNCT03655223
What this trial is testing

Early Check: Expanded Screening in Newborns

Who this might be right for
Spinal Muscular AtrophyFragile X SyndromeFragile X - Premutation+182 more
RTI International 30,000
Large-scale testing (Phase 3)Looking for participantsNCT07582432
What this trial is testing

A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma

Who this might be right for
Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma
Grifols Biologicals, LLC 49
Not applicableStudy completedNCT00828243
What this trial is testing

Genetic Regulation of Surfactant Deficiency

Who this might be right for
Respiratory Distress Syndrome, Newborn
Washington University School of Medicine 525
Not applicableStudy completedNCT01328704
What this trial is testing

Evaluate the Change in Iron, Vitamin D, and C-Reactive Protein Level (CRP) in a 12 to 24 Week Period

Who this might be right for
AnemiaVitamin D Deficiency
Avera McKennan Hospital & University Health Center 50
Not applicableStudy completedNCT00626223
What this trial is testing

5-methyltetrahydrofolate Survival and Inflammation in ESRD Patients

Who this might be right for
MortalityHyperhomocysteinemiaInflammation
IRCCS Azienda Ospedaliero-Universitaria di Bologna 341
Not applicableEnded earlyNCT00340548
What this trial is testing

Host Genetic Factors Influencing HIV1 and HCV Viral Loads and AIDS Clinical Progression in a Hemophilia Cohort (HGDS-3)

Who this might be right for
HemophiliaAIDS
National Cancer Institute (NCI) 333
Not applicableStudy completedNCT00161720
What this trial is testing

Retrospective Study to Capture Dosing and Treatment Outcome Data in Participants With Severe Congenital Protein C Deficiency Who Were Treated With Protein C Concentrate Under an Emergency Use IND

Who this might be right for
Protein C Deficiency
Baxalta now part of Shire 11
Early research (Phase 1)Study completedNCT03307915
What this trial is testing

2 Different Regimens of Tetravalent Ad26.Mos4.HIV Prime Followed by Boost With Modified Vaccinia Ankara (MVA)-Mosaic OR Ad26.Mos4.HIV Plus a Combination of Mosaic and Clade C gp140 Protein in Human Immunodeficiency Virus (HIV) Type 1 Infected Adults on Suppressive Antiretroviral Treatment

Who this might be right for
Human Immunodeficiency Virus
Janssen Vaccines & Prevention B.V. 25
Testing effectiveness (Phase 2)Study completedNCT00055341
What this trial is testing

Treatment of Hepatitis C in Hemophilic Patients With HIV

Who this might be right for
HIV InfectionsHepatitis CHemophilia
National Institute of Allergy and Infectious Diseases (NIAID) 22
Large-scale testing (Phase 3)Study completedNCT00157118
What this trial is testing

Efficacy and Safety Study of Protein C Concentrate in Subjects With Severe Congenital Protein C Deficiency

Who this might be right for
Protein C Deficiency
Baxalta now part of Shire 18
Not applicableLooking for participantsNCT06590974
What this trial is testing

Freeze-dried Human Protein C Concentrate (TAK-662) in Participants With Congenital Protein C Deficiency

Who this might be right for
Protein C Deficiency
Takeda 7
Testing effectiveness (Phase 2)Study completedNCT03122223
What this trial is testing

Evaluating the Safety and Immunogenicity of ALVAC-HIV and MF59®- or AS01B-adjuvanted Bivalent Subtype C gp120 in Healthy, HIV-uninfected Adult Participants

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 160
Early research (Phase 1)Study completedNCT03409276
What this trial is testing

Evaluating the Safety and Immunogenicity of Env (A,B,C,A/E)/Gag (C) DNA and gp120 (A,B,C,A/E) Protein/GLA-SE HIV Vaccines, Given Individually or Co-administered, in Healthy, HIV-1-Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 60
Large-scale testing (Phase 3)Study completedNCT00220766
What this trial is testing

Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency Patients

Who this might be right for
Immunologic Deficiency SyndromeAgammaglobulinemiaSevere Combined Immunodeficiency+2 more
Grifols Therapeutics LLC 100
Not applicableStudy completedNCT01127529
What this trial is testing

Ceprotin Treatment Registry

Who this might be right for
Protein C Deficiency
Baxalta now part of Shire 43
Testing effectiveness (Phase 2)Study completedNCT02915016
What this trial is testing

Evaluating the Safety and Immunogenicity of HIV Clade C DNA Vaccine and MF59- or AS01B-Adjuvanted Clade C Env Protein Vaccines in Various Combinations in Healthy, HIV-Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 334
Early research (Phase 1)Study completedNCT04927585
What this trial is testing

Evaluating the Safety and Immunogenicity of Polyvalent DNA/gp120 HIV Vaccine in Healthy, HIV-uninfected Adults

Who this might be right for
HIV Infections
Worcester HIV Vaccine 42
Load More Results